[PDF] Primary care prescribing analysis – drugs used in diabetes

Source:
All Wales Medicines Strategy Group - AWMSG
Publisher:
All Wales Medicines Strategy Group (AWMSG)
Publication date:
31 August 2015

Abstract

This report has been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG) and the All Wales Therapeutics and Toxicology Centre (AWTTC), and has subsequently been endorsed by the All Wales Medicines Strategy Group (AWMSG).

Prescribing of medicines used in diabetes in 2014–2015 accounted for £57.2 million (9.8% of total medicines expenditure in NHS Wales) and 3,273,664 items (4.2%) in primary care, and £2.6 million (1.5%) in secondary care. Prescribing via the WP10HP route amounted to £78,668 (6,319 items).